126 related articles for article (PubMed ID: 16484001)
41. Pathology of malignant mesothelioma.
Van Marck E
Lung Cancer; 2004 Aug; 45 Suppl 1():S35-6. PubMed ID: 15261431
[TBL] [Abstract][Full Text] [Related]
42. Platelet-derived growth factor expression correlates with tumor grade and proliferative activity in human oligodendrogliomas.
Majumdar K; Radotra BD; Vasishta RK; Pathak A
Surg Neurol; 2009 Jul; 72(1):54-60. PubMed ID: 19559929
[TBL] [Abstract][Full Text] [Related]
43. Activation of telomerase by human cytomegalovirus.
Strååt K; Liu C; Rahbar A; Zhu Q; Liu L; Wolmer-Solberg N; Lou F; Liu Z; Shen J; Jia J; Kyo S; Björkholm M; Sjöberg J; Söderberg-Nauclér C; Xu D
J Natl Cancer Inst; 2009 Apr; 101(7):488-97. PubMed ID: 19318640
[TBL] [Abstract][Full Text] [Related]
44. Telomerase activity in sputum and telomerase and its components in biopsies of advanced lung cancer.
Pasrija T; Srinivasan R; Behera D; Majumdar S
Eur J Cancer; 2007 Jun; 43(9):1476-82. PubMed ID: 17531468
[TBL] [Abstract][Full Text] [Related]
45. Evaluation of myocyte proliferation in alcoholic cardiomyopathy: telomerase enzyme activity (TERT) compared with Ki-67 expression.
Lluís M; Fernández-Solà J; Castellví-Bel S; Sacanella E; Estruch R; Urbano-Márquez A
Alcohol Alcohol; 2011; 46(5):534-41. PubMed ID: 21733836
[TBL] [Abstract][Full Text] [Related]
46. Increased human telomerase reverse transcriptase (hTERT) mRNA expression but not telomerase activity is related to survival in curatively resected non-small cell lung cancer.
Metzger R; Vallbohmer D; Müller-Tidow C; Higashi H; Bollschweiler E; Warnecke-Eberz U; Brabender J; Baldus SE; Xi H; Berdel WE; Serve H; Hoelscher AH; Schneider PM
Anticancer Res; 2009 Apr; 29(4):1157-62. PubMed ID: 19414359
[TBL] [Abstract][Full Text] [Related]
47. Expression of Mcm-2, Ki-67 and geminin in benign and malignant salivary gland tumours.
Vargas PA; Cheng Y; Barrett AW; Craig GT; Speight PM
J Oral Pathol Med; 2008 May; 37(5):309-18. PubMed ID: 18248354
[TBL] [Abstract][Full Text] [Related]
48. Immunohistochemical determination of the appropriate anti-hTERT antibodies for in situ detection of telomerase activity in frozen sections of head and neck squamous cell carcinomas and tumor margin tissues.
Fabricius EM; Kruse-Boitschenko U; Khoury R; Wildner GP; Raguse JD; Klein M
Int J Oncol; 2009 May; 34(5):1257-79. PubMed ID: 19360339
[TBL] [Abstract][Full Text] [Related]
49. Immunocytochemical panel for distinguishing carcinoma cells from reactive mesothelial cells in pleural effusions.
Wu GP; Zhang SS; Fang CQ; Liu SL; Wang EH
Cytopathology; 2008 Aug; 19(4):212-7. PubMed ID: 18699986
[TBL] [Abstract][Full Text] [Related]
50. Cell proliferation in feline normal, hyperplastic and neoplastic mammary tissue--an immunohistochemical study.
Dias Pereira P; Carvalheira J; Gärtner F
Vet J; 2004 Sep; 168(2):180-5. PubMed ID: 15301767
[TBL] [Abstract][Full Text] [Related]
51. UHRF1 Immunohistochemical Staining Separates Benign Reactive Spindle Cell Mesothelial Proliferations From Sarcomatoid Mesotheliomas.
Yang H; Cheung S; Churg A
Am J Surg Pathol; 2022 Jun; 46(6):840-845. PubMed ID: 34772842
[TBL] [Abstract][Full Text] [Related]
52. Prognostic value of histologic and immunohistochemical features in feline cutaneous mast cell tumors.
Sabattini S; Bettini G
Vet Pathol; 2010 Jul; 47(4):643-53. PubMed ID: 20418469
[TBL] [Abstract][Full Text] [Related]
53. Effect of Helicobacter pylori eradication on oncogenes and cell proliferation.
Zhu Y; Shu X; Chen J; Xie Y; Xu P; Huang DQ; Lu NH
Eur J Clin Invest; 2008 Sep; 38(9):628-33. PubMed ID: 18837738
[TBL] [Abstract][Full Text] [Related]
54. Development of a novel assay to quantify serum human telomerase reverse transcriptase messenger RNA and its significance as a tumor marker for hepatocellular carcinoma.
Miura N; Maruyama S; Oyama K; Horie Y; Kohno M; Noma E; Sakaguchi S; Nagashima M; Kudo M; Kishimoto Y; Kawasaki H; Hasegawa J; Shiota G
Oncology; 2007; 72 Suppl 1():45-51. PubMed ID: 18087181
[TBL] [Abstract][Full Text] [Related]
55. Lymph node metastases, not human telomerase reverse transcriptase or p53 proteins, as the strongest prognostic factor for survival in early stage cervical cancer.
Tee YT; Wang PH; Yang SF; Ng SC; Ko JL; Chen GD; Chang H; Lin LY
J Obstet Gynaecol Res; 2008 Dec; 34(6):1002-9. PubMed ID: 19012699
[TBL] [Abstract][Full Text] [Related]
56. Expression of human telomerase reverse transcriptase, Survivin, DD3 and PCGEM1 messenger RNA in archival prostate carcinoma tissue.
Bialkowska-Hobrzanska H; Driman DK; Fletcher R; Harry V; Razvi H
Can J Urol; 2006 Feb; 13(1):2967-74. PubMed ID: 16515751
[TBL] [Abstract][Full Text] [Related]
57. c-MET immunohistochemistry for differentiating malignant mesothelioma from benign mesothelial proliferations.
Ren HZ; Cheung S; Churg A
Hum Pathol; 2020 Nov; 105():31-36. PubMed ID: 32916162
[TBL] [Abstract][Full Text] [Related]
58. Mad1 suppresses bladder cancer cell proliferation by inhibiting human telomerase reverse transcriptase transcription and telomerase activity.
Zou L; Zhang P; Luo C; Tu Z
Urology; 2006 Jun; 67(6):1335-40. PubMed ID: 16765199
[TBL] [Abstract][Full Text] [Related]
59. Prognostic significance of Ki-67 antigen expression in non-Hodgkin's lymphomas.
Szczuraszek K; Mazur G; Jeleń M; Dziegiel P; Surowiak P; Zabel M
Anticancer Res; 2008; 28(2A):1113-8. PubMed ID: 18507062
[TBL] [Abstract][Full Text] [Related]
60. Expression patterns of Ki-67 and telomerase activity in middle ear cholesteatoma.
Kuczkowski J; Pawelczyk T; Bakowska A; Narozny W; Mikaszewski B
Otol Neurotol; 2007 Feb; 28(2):204-7. PubMed ID: 17255888
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
